Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Progress at Oxford BioMedica in targeted cancer therapy program

Feb. 10, 2000

Xenova enters telomerase research agreement with Brunel University

Feb. 10, 2000

Targretin gel formulation granted priority review status

Feb. 9, 2000

NuChem anticancer agent inhibits human melanoma metastasis in mice

Feb. 9, 2000

Novogen initiates phase I clinical trial with potential prostate cancer treatment

Feb. 9, 2000

Lorus Therapeutics receives US patent for antisense cancer therapies

Feb. 9, 2000

U.S. patent issued for B-cell lymphoma therapy

Feb. 9, 2000

Porphyrins designed at Schering for PDT and MRI

Feb. 9, 2000

Chinese investigators design novel antitumor agents

Feb. 8, 2000

Roche announces limitations on availability of FUDR

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...